NDC11 00469064773
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00469-0647-73 | 00469-0647 |
| 00469-647-73 | 00469-647 |
| 0469-0647-73 | 0469-0647 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ASTAGRAF XL | TACROLIMUS EXTENDED-RELEASE CAPSULES | Astellas Pharma US, Inc. | 550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 0469-0647-73 0469-0647 00469064773 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.